Correction of lysosomal dysfunction as a therapeutic strategy for neurodegenerative diseases.

Abstract excerpt

Mutations in the gene that encodes the lysosomal enzyme acid β-glucosidase lead to reduced cellular activity and accumulation of glycosphingolipid substrates, biochemical hallmarks of the lysosomal storage disorder Gaucher disease (GD). Recently such mutations have been identified as risk factors...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Glucosylceramidase
• Share to Lysosomes